Quantitative determination of 1-hexylcarbamoyl-5-fluorouracil and its metabolites in man. 1981

O Nakajima, and Y Yoshida, and T Isoda, and Y Takemasa, and Y Imamura, and Y Koyama

A high-performance liquid chromatographic (HPLC) method for the quantitative determination of 1-hexylcarbamoyl-5-fluorouracil (HCFU) and its metabolites using mu Bondapak C18 and mu Porasil has been developed. Two mobile phases containing PIC-B7 (consisting of acetic acid and 1-heptanesulphonic acid) were used for the separation, and good separations were obtained. With methanol-water (56:44) as the mobile phase, the separation of HCFU and its three metabolites was achieved within 4 min. With methanol-water (32:68) a new metabolite, 1-omega-carboxymethylcarbamoyl-5-fluorouracil, was revealed in human plasma. The recovery of each substance was 80% or greater and the sensitivity was at the nanograms per millilitre level. The coefficient of variation was less than 3.6% for each component.

UI MeSH Term Description Entries
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D005472 Fluorouracil A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid. 5-FU,5-FU Lederle,5-FU Medac,5-Fluorouracil,5-Fluorouracil-Biosyn,5-HU Hexal,5FU,Adrucil,Carac,Efudex,Efudix,Fluoro-Uracile ICN,Fluoroplex,Fluorouracil Mononitrate,Fluorouracil Monopotassium Salt,Fluorouracil Monosodium Salt,Fluorouracil Potassium Salt,Fluorouracil-GRY,Fluorouracile Dakota,Fluorouracilo Ferrer Far,Fluoruracil,Fluracedyl,Flurodex,Haemato-FU,Neofluor,Onkofluor,Ribofluor,5 FU Lederle,5 FU Medac,5 Fluorouracil,5 Fluorouracil Biosyn,5 HU Hexal,Dakota, Fluorouracile,Fluoro Uracile ICN,Fluorouracil GRY,Haemato FU
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

O Nakajima, and Y Yoshida, and T Isoda, and Y Takemasa, and Y Imamura, and Y Koyama
May 1979, Journal of chromatography,
O Nakajima, and Y Yoshida, and T Isoda, and Y Takemasa, and Y Imamura, and Y Koyama
April 1980, Journal of chromatography,
O Nakajima, and Y Yoshida, and T Isoda, and Y Takemasa, and Y Imamura, and Y Koyama
September 1978, Xenobiotica; the fate of foreign compounds in biological systems,
O Nakajima, and Y Yoshida, and T Isoda, and Y Takemasa, and Y Imamura, and Y Koyama
June 1981, Cancer treatment reviews,
O Nakajima, and Y Yoshida, and T Isoda, and Y Takemasa, and Y Imamura, and Y Koyama
July 1981, Journal of pharmacobio-dynamics,
O Nakajima, and Y Yoshida, and T Isoda, and Y Takemasa, and Y Imamura, and Y Koyama
January 1988, Chemotherapy,
O Nakajima, and Y Yoshida, and T Isoda, and Y Takemasa, and Y Imamura, and Y Koyama
February 1981, Journal of the National Cancer Institute,
O Nakajima, and Y Yoshida, and T Isoda, and Y Takemasa, and Y Imamura, and Y Koyama
October 1987, European journal of cancer & clinical oncology,
O Nakajima, and Y Yoshida, and T Isoda, and Y Takemasa, and Y Imamura, and Y Koyama
November 1984, Gan to kagaku ryoho. Cancer & chemotherapy,
Copied contents to your clipboard!